Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Novavax Inc (NQ: NVAX )

132.50 USD +1.04 (+0.79%)
Streaming Delayed Price Updated: 7:35 AM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Novavax Inc

< Previous 1 2 3 4 5 6 7 8 9
...
71 72 Next >
Return On Capital Employed Overview: Novavax
During Q3, Novavax's (NASDAQ: NVAX) reported sales totaled $157.02 million. Despite a 1039.03% in earnings, the company posted a ... 
Tags News NVAX Market News
From Benzinga
These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020
Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing. 
Tags MRNA INO ARCT
From Motley Fool
3 Best Biotech Stocks of 2020: Are They Buys Now?
There are plenty of catalysts on the horizon for these investments -- and a healthy dose of risk. 
Tags PFE NVAX Market News
From Motley Fool
Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine Race
A biotech company and a big pharma player each offer something that sets them apart from rivals. 
Tags JNJ MRNA NVAX
From Motley Fool
Moderna Analyst Positive On Coronavirus Vaccine Progress, Downgrades Shares On Valuation
Moderna Inc (NASDAQ: MRNA) has been one of the best performing stocks of 2020thanks to its COVID-19 vaccine development ... 
Tags Biotech Movers Alan Carr
From Benzinga
Looking For The Best Biotech Stocks To Buy Now? 2 Up By Over 300% YTD
From Stockmarket.com
Analyzing Novavax's Unusual Options Activity
Shares of Novavax (NASDAQ: NVAX) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved ... 
Tags Options Markets Market News
From Benzinga
Why Novavax Stock Crushed It in November
A rival's setback could translate into a major windfall for this mid-cap biotech company. 
Tags AZN IBB NVAX
From Motley Fool
How to Buy Coronavirus Vaccine Stocks in 2021
Are the big gains over? No. But the game is changing. 
Tags Market News NVAX MRNA
From Motley Fool
$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest Winners
The companies with the biggest gains won't necessarily be those with the highest sales of coronavirus vaccines. 
Tags MRNA NVAX Market News
From Motley Fool
Bill Gates Says 6 COVID-19 Vaccines Likely To Get Regulatory Approval By Q1
Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates said that nearly half a dozen vaccines from different manufacturers could be ... 
Tags Media BNTX Biotech
From Benzinga
I’m already trying out a COVID vaccine. But can I get another one injected, in case it was a placebo?
"Will I be inoculated against coronavirus twice --- with two different vaccines? Or will I, on the other hand, miss my chance altogether?" writes Pierre Briançon of volunteering for a vaccine trial in... 
Tags PFE BNTX NVAX
From MarketWatch
Is Novavax Still a Buy After Jumping 3,000%?
The No. 1 stock of 2020 still has a lot of room to run... and a lot of room to fall. 
Tags Market News NVAX
From Motley Fool
AstraZeneca Follows Pfizer In Seeking India Emergency Use Approval For COVID-19 Vaccine
AstraZeneca Plc’s (NASDAQ: AZN) partner,the Serum Institute of India, applied for emergency use authorization of the ... 
Tags Government General Biotech
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags BCRX VERU VRTX
From Benzinga
This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far
You'll probably be surprised at just great the returns from investing in this stock have been. 
Tags AZN PFE Market News
From Motley Fool
The Flu Gives This Coronavirus Vaccine Stock A Surprising Edge
Combining vaccines for multiple viruses could boost sales. 
Tags SNY MRNA NVAX
From Motley Fool
3 Coronavirus Vaccine Stocks That Still Have Strong Upside
These three could deliver big for investors once their vaccines are approved for sale. 
Tags Market News NVAX PFE
From Motley Fool
Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch
Don't be surprised if this small biotech takes off in 2021. 
Tags NVAX Market News ARCT
From Motley Fool
2 Reasons It's Not Too Late to Buy Moderna
There's more ahead than just a regulatory green light. 
Tags JNJ VXRT XLV
From Motley Fool
Pfizer And Moderna Face Their Biggest Challenge: Vaccinating The World
In less than a year, Pfizer and Moderna did what usually takes drugmakers decades. But the coronavirus vaccine stocks now face a hurdle: Vaccinating the world. 
From Investor's Business Daily
2 Surprising Coronavirus Vaccine Stocks to Buy Right Now
If we judge by return on investment, these two mid-cap biotechs may be the ultimate winners of the coronavirus vaccine race. 
Tags NVAX Market News MRNA
From Motley Fool
As Biotech Thrives On Vaccine Hopes, Traders Look Into The Sector's Diversity
If there is one prevailing trend that Wall Street is counting on during this period of great economic and social uncertainty, it’s ... 
Tags vantagepoint Benzinga MRNA
From Benzinga
Why We Need All 5 of These Coronavirus Vaccine Companies to End the Pandemic
It's time to count how many vaccine doses leading companies can provide -- and how many may be needed. 
Tags JNJ MRNA PFE
From Motley Fool
COVID Vaccine Stocks Update: Where Things Stand Now
Here's what you need to know about all of the leaders in the coronavirus vaccine race. 
Tags JNJ MRNA CVAC
From Motley Fool
Noteworthy Tuesday Option Activity: NVAX, RGS, INSP
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Novavax, Inc. (NVAX), where a total volume of 42,989 contracts has been traded thus... 
Tags Stocks
From Market News Video
Want to Invest in Coronavirus Vaccines? Consider This First
The differences between the vaccines could affect the eventual winner (if there is one). 
Tags PFE AZN JNJ
From Motley Fool
Could These Biotech Stocks Be A Bigger COVID-19 Vaccine Winner Than Pfizer?
From Stockmarket.com
2 Ultra-Risky Coronavirus Stocks That Could Make You Filthy Rich
They'll be later to market than rivals. But if their product candidates are stronger, investors may reap rewards. 
Tags NVAX Market News VIR
From Motley Fool
Is Novavax Stock a Buy?
How much opportunity will exist for the company's vaccines by the time they are on the market? 
Tags NVAX Market News MRNA
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
71 72 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.